Registration Price Increase Effective December 2nd

Register Now

Keynote & Panels

In addition to 100 medtech startups, the event will also feature panels and presentations from the leaders that have done and are doing deals.

The Next Quantum Leaps in Medtech

In his keynote address, Christopher Velis, founder of Auris Health and Miraki Innovation shares insights on a repeatable process for quantum leaps of innovation. As challenges in global healthcare increase and become more urgent, momentous progress is critical. Next generation medtech companies must think beyond incremental progress while also developing lifesaving companies without missteps or delay. Auris Health was the largest medtech venture funded transaction in history, acquired by Johnson & Johnson for a total of $5.75 billion. Christopher’s method, used to develop Auris and other leading medtech companies, identifies future demands and efficiently and effectively builds the solutions to those pressing market needs. Christopher discusses the Auris story and where he sees the next big opportunities (and challenges) in medtech innovation.

Christopher J. Velis

Christopher J. Velis

Founder & Executive Chairman, Miraki Innovation

Keynote

Interview with a Medtech Legend

Join us for a fireside chat with industry legend and prolific entrepreneur, Dr. Manny Villafaña .  We'll hear the stories and insights behind how Manny built St. Jude Medical, ATS Medical, and Cardiac Pacemakers Inc.  We'll also find out what he's up to with his next venture, Medical 21.

Manny is the co-inventor of the first lithium powered pacemaker and founder of Cardiac Pacemakers, Inc./Guidant.  He is also the co-developer of the St. Jude heart valve and Founder of St. Jude Medical, Inc.  He's also co-inventor of the ATS heart valve and Founder of ATS Medical, Inc. (now part of Medtronic).  

Manny currently serves as the Founder, Chairman, & CEO of Medical 21, Inc.  Dr. Villafaña is globally recognized as a “Living Legend of Medicine.”  He is an award-winning USA Master Entrepreneur, a member of the Halls of Fame of Minnesota Business and Science & Technology.  He is the past founder of medical device companies that  have transformed the industry of cardiac surgery and improved the lives of millions.  Manny is also the recipient of an honorary Doctorate of Sciences degree from the University of Iowa.

Manny Villafaña, PhD, Sc

Manny Villafaña, PhD, Sc

CEO, Medical 21

Fireside Chat

Venture Capital Investing in Medtech

In this panel we'll talk to active VCs about the types of deals they are in now, and more importantly, we'll find out what new deals they are looking at in 2020.

Jon Root

Jon Root

General Partner, US Venture Partners

Panelist

John F. Ryan

John F. Ryan

Managing Director, Wells Fargo Strategic Capital

Panelist

Janelle Goulard

Janelle Goulard

Director of Health Investment, Pangaea Ventures

Panelist

Mar Perez

Mar Perez

Principal, InCube Ventures

Panelist

Michael Thomas

Michael Thomas

Investment Director, Inova Venture Capital

Panelist

Howard Levin, MD

Howard Levin, MD

Managing Partner, Coridea

Panelist

The Strategic Outlook on Medtech Deal-Making

In this panel we'll get insights from leading medtech strategics J&J, Medtronic, Terumo, and Intuitive Surgical.  We will discuss the types of deals they are looking for and have each stakeholder weigh in on deal structure trends and provide a perspective on where they see M&A in 2020 and beyond.    

We will also learn about an important global strategic partnership formed in 2019 between Terumo & Orchestra BioMed and how this innovative approach to risk/reward sharing for product development and commercialization might shape future deal-making opportunities for strategics and innovators.

 

Nicholas Pachuda

Nicholas Pachuda

WW VP, Orthopedic Innovation, J&J Medical Devices

Panelist

Julian Nikolchev

Julian Nikolchev

Senior VP Corporate Development & Strategy, Intuitive Surgical

Panelist

David Hochman

David Hochman

Chairman & CEO, Orchestra BioMed

Panelist

Earl Slee

Earl Slee

VP, Technology, Strategy & Business Development, Medtronic

Panelist

Insights and Opinions From Big Company Executives Turned Entrepreneurs

In this panel we’ll hear the experiences and insights from ex- big company executives who’ve chosen the entrepreneurial path and are now leading early stage medtech ventures.  We’ll have them share war stories, perspectives of being on both sides of the table, and find out what they are up to next -- and why.  The executives on this panel have held senior positions with the some of the largest medtech strategics and have multiple exits under their belts as entrepreneurs. 

Join us for an informative (and fun) discussion with panelists Jim Corbett (Boston Scientific, ev3, MicroTherapeutics, Alphatec Spine), Todd Usen (Olympus, Smith & Nephew, Boston Scientific), Brian Verrier (Covidien, Medtronic), Paul Molloy (Telefex, VasoNova, Micardia), and Tim Moran (ConvaTec, Covidien).

The panel will be moderated by industry insider and Alira Health Senior Partner & VP, David Uffer.

Jim Corbett

Jim Corbett

CEO, CathWorks

Panelist

Brian Verrier

Brian Verrier

CEO, Ossio

Panelist

Todd Usen

Todd Usen

CEO, Activ Surgical

Panelist

Timothy P. Moran

Timothy P. Moran

CEO, Motus GI

Panelist

Paul Molloy

Paul Molloy

CEO, ClearFlow

Panelist

David Uffer

David Uffer

Senior Partner & VP, Alira Health

Moderator

Early Reimbursement & Market Access Planning: It's Not Optional

In this panel we'll get a "from the trenches" perspective on reimbursement and market access strategies directly from the key stakeholders; the CEO, Strategic Investor, Venture Capitalist, and Payer.  This group will share their insights and experiences (some positive, some painful) on why having a proper reimbursement and market access strategy is so critical. 

The panel will be moderated by medtech industry veteran and reimbursement thought leader, Tonya Dowd.  Tonya is MCRA's Vice President of Reimbursement, Health Economics and Market Access.

Lisa Wipperman Heine

Lisa Wipperman Heine

CEO, PreCardia

Panelist

Tonya Dowd

Tonya Dowd

Vice President, MCRA

Moderator

Non-Traditional VC, Family Office, Angel & CrowdSourcing in 2020

In this panel we’ll hear from active medtech angels, family office, and other non-traditional early stage investors.  What are they investing in?  What are they bringing to the table besides capital?  What kind of deals are they interested in right now? 

This group of panelists represent a new CrowdSourcing & Direct Investment Platform, 4 Lifescience Angel Groups, 2 Family Offices, and a new VC fund focused exclusively on early-stage deals.

Kevin Schimelfenig

Kevin Schimelfenig

Managing Partner, McGeever Family Office

Panelist

Rob Ball

Rob Ball

Managing Director, Genesis & CultivateMD Fund

Panelist

Greg Scott

Greg Scott

Co-Founder, BioPacific Investors, Chairman, ChinaBio Group

Panelist

Brian Smith

Brian Smith

CEO, RedCrow, Direct Investment Platform

Panelist

Ben Joseph

Ben Joseph

President, Mend Medical, Ambassador Family Office

Panelist

Scott Pantel

Scott Pantel

CEO, Life Science Intelligence

Moderator